DIMERIX EXPANDS PIPELINE WITH ACQUISITION OF PHASE 2 READY ASSET FOR ACUTE KIDNEY INJURY

DMX-652Positive

AI Analysis

Summary

Dimerix acquired DMX-652, a Phase 2-ready asset for acute kidney injury treatment, with an open US IND application enabling potential rapid advancement into clinical trials.

Clinical Trial Data

Phase

Phase 2

Outcome Details

Phase 2-ready asset acquisition with open US IND application

Importance:6/10

Sentiment:

0.60

acquisitionpipeline expansionPhase 2acute kidney injuryIND application

Related Companies

$RTSL

Read the original article

Published by PR Newswire Pharma on July 17, 2026 11:00 AM

Read Original